USPTO serial 74007095
ENDOSTATIN
Reviewed by CopyMark Law Group
Status 605
- Filing date
- Status date
- Registration date
- —
- Examiner
- SZOKE, MICHAEL
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ENDOSTATIN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
PAUL T. CLARK
PAUL T CLARK FISH & RICHARDSONONE FINANCIAL CTR STE 2500BOSTON, MA 02111-2658UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | PHARMACEUTICALS - NAMELY, ANTICANCER AGENTS AND PHARMACEUTICALS FOR THE TREATMENT OF VASCULAR DISORDERS | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 8, 1990 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Nov 1, 1990 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Apr 17, 1990 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 17, 1990 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 20, 1990 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |